Overall national health spending grew at a rate of 3.9 percent in 2017, almost 1.0 percentage point slower than growth in 2016, according to a study conducted by the Office of the Actuary at the Centers for Medicare & Medicaid Services (CMS) and published today as a Web First by Health Affairs.
Today, Centers for Medicare & Medicaid Services’ (CMS) Administrator Seema Verma—in an address to the States and Nation Policy Summit of the American Legislative Exchange Council (ALEC) in Washington, D.C.—shared her vision for innovations and reforms that will empower states and provide the flexibility states need to create alternatives to the Affordable Care Act (ACA) that improve health insurance options.
Every week during Open Enrollment, the Centers for Medicare & Medicaid Services (CMS) will release enrollment snapshots for the HealthCare.gov platform, which is used by the Federally-facilitated Exchanges, the State Partnership Exchanges, and some State-based Exchanges. Week 4 captures enrollment figures for Nov 18-24, 2018.
This report provides average effectuated enrollment and premium data for the Federal and State-Based Exchanges for the first six months of the 2018 plan year.
The Centers for Medicare & Medicaid Services (CMS) developed a new ‘enhanced’ direct enrollment pathway for consumers to enroll in health insurance coverage through the Federally-facilitated Exchange.
The Centers for Medicare & Medicaid Services (CMS) launched a new online tool that allows consumers to compare Medicare payments and copayments for certain procedures that are performed in both hospital outpatient departments and ambulatory surgical centers.
CMS is committed to implementing President Trump’s blueprint to lower drug costs and reduce out-of-pocket costs for patients. In line with the policies discussed in the President’s blueprint, CMS issued a proposed rule on November 26, 2018 that solicits public comments on potential policies that would remove administrative hurdles to offer lower cost options to seniors and provide support for private sector partners by providing them the tools to lower the cost of prescription drugs.